Back to KERX Stock Lookup
Pages: 1 2 3 »» Last Page

Keryx Biopharma (KERX) – Press Releases

Nov 18, 2016 10:31 AM Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week
Nov 17, 2016 10:31 AM Keryx Biopharmaceuticals Announces Multiple Scientific Presentations of Phase 3 Trial Results of Ferric Citrate for Iron Deficiency Anemia (IDA) in Non-Dialysis Dependent Chronic Kidney Disease (NDD-C
Nov 9, 2016 10:42 AM Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia® (ferric citrate)
Nov 9, 2016 07:01 AM Keryx Biopharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 3, 2016 08:31 AM Keryx Biopharmaceuticals to Webcast its Presentation at Stifel’s 2016 Healthcare Conference on November 15
Nov 1, 2016 09:15 AM Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
Oct 14, 2016 10:13 AM Keryx Biopharmaceuticals Announces Presentations of Data at the American Society of Nephrology Kidney Week 2016 Annual Meeting
Sep 27, 2016 04:08 PM October 3rd Deadline Alert: GPM Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Keryx Pharmaceuticals, Inc. and Announces Expanded Class Period
Sep 21, 2016 08:30 AM Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference
Sep 20, 2016 11:38 AM GPM Reminds Investors of the October 3rd Deadline in the Class Action Lawsuit Against Keryx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Sep 1, 2016 08:30 AM Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences
Aug 8, 2016 02:43 PM IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm
Aug 4, 2016 11:11 AM IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm
Aug 3, 2016 12:47 PM IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm
Aug 3, 2016 10:06 AM INVESTOR ALERT: Class Action Lawsuit on Behalf of Investors in Keryx Biopharmaceuticals Announced by Holzer & Holzer
Aug 2, 2016 10:14 PM SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses to Contact the Firm
Aug 2, 2016 05:02 PM Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Keryx Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
Aug 2, 2016 11:55 AM IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Keryx Biopharmaceuticals Inc. and Advises Investors with Losses to Contact the Firm
Aug 2, 2016 10:50 AM Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Keryx Biopharmaceuticals, Inc.
Aug 2, 2016 09:45 AM INVESTOR ALERT: Investigation of Keryx Biopharmaceuticals Announced by Holzer & Holzer LLC
Aug 1, 2016 08:53 PM INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Keryx Biopharmaceuticals Inc. and Advises Investors with Losses to Contact the Firm
Aug 1, 2016 06:41 PM Glancy Prongay & Murray Commences Investigation on Behalf of Keryx Pharmaceuticals, Inc. Investors
Aug 1, 2016 07:30 AM Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results
Jul 29, 2016 08:30 AM Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2016 Financial Results on Monday, August 1, 2016
Jun 27, 2016 08:00 AM Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy
Jun 23, 2016 08:00 AM Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors
Jun 21, 2016 08:00 AM Keryx Biopharmaceuticals Appoints Two New Board Members
Jun 14, 2016 08:30 AM Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21
Apr 28, 2016 07:00 AM Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results
Apr 14, 2016 08:30 AM Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on Thursday, April 28, 2016
Apr 1, 2016 08:30 AM Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors
Mar 29, 2016 06:30 AM Keryx Biopharmaceuticals Announces Positive Top-line Results from Pivotal  Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia  in Adults with Non-Dialysis Dependent Chronic
Mar 1, 2016 08:30 AM Keryx Biopharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7
Feb 25, 2016 07:00 AM Keryx Biopharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results
Feb 11, 2016 08:00 AM Keryx Biopharmaceuticals to Host Conference Call on Fourth Quarter and Year End 2015 Financial Results on Thursday, February 25, 2016
Dec 22, 2015 04:05 PM Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11
Dec 10, 2015 08:00 AM Keryx Announces Appointment of John P. Butler to its Board of Directors
Dec 1, 2015 09:05 AM Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare Conference
Nov 3, 2015 04:05 PM Keryx Biopharmaceuticals Announces Participation at Two Upcoming Investor Conferences
Oct 29, 2015 07:00 AM Keryx Biopharmaceuticals Announces Third Quarter 2015 Financial Results
Oct 21, 2015 09:05 AM Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2015 Financial Results on Thursday, October 29, 2015
Oct 15, 2015 07:00 AM Keryx Biopharmaceuticals Announces $125 Million Private Placement of Convertible Senior Notes With The Baupost Group, L.L.C.
Sep 24, 2015 07:00 AM Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Sep 24, 2015 07:00 AM Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Sep 9, 2015 08:30 AM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Aug 5, 2015 07:00 AM Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results
Aug 5, 2015 07:00 AM Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results
Jul 28, 2015 04:05 PM Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015
Jul 28, 2015 04:05 PM Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015
Jul 27, 2015 08:00 AM Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer
Pages: 1 2 3 »» Last Page

Back to KERX Stock Lookup